Health and Human Services (HHS) Secretary Alex Azar, MD, asked FDA Commissioner Scott Gottlieb, MD, to establish a working group to examine how to safely import prescription generic drugs in the event of a dramatic price increase for a drug produced by one manufacturer and not protected by patents or exclusivities.
“We have seen a number of both branded and generic examples in recent years where a single manufacturer dramatically hikes the price for a drug unprotected by patent or